ABVC BioPharma, Inc. Fair Value Adjustment of Warrants
ABVC BioPharma, Inc. (ABVC) reported Fair Value Adjustment of Warrants of $925.21 thousand for the 9-month period ending 2025-09-30, per its 10-Q/A filed 2026-03-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-03
- ABVC BioPharma, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- ABVC BioPharma, Inc. fair value adjustment of warrants for the quarter ending 2024-06-30 was $925.21K.
- ABVC BioPharma, Inc. fair value adjustment of warrants for the quarter ending 2024-03-31 was $394.07K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $925.21K 10-Q/A · filed 2026-03-03 | ||
| 2025-07-15 | $798.49K 10-K · filed 2026-03-03 | |||
| 2025-06-30 | $925.21K 10-Q · filed 2025-08-13 | |||
| 2024-09-30 | $925.21K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $925.21K 10-Q · filed 2024-08-14 | $1.32M derived: sum of 2 quarters · filed 2024-08-14 | ||
| 2024-05-22 | $925.21K 10-Q · filed 2025-04-30 | |||
| 2024-03-31 | $394.07K 10-Q · filed 2024-05-17 | |||
| 2024-01-17 | $394.07K 10-Q · filed 2024-11-14 | |||
| 2023-11-17 | $480.80K 10-Q/A · filed 2026-03-03 | |||
| 2023-02-23 | $1.23M 10-K · filed 2024-03-13 |